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Background: In an ongoing outbreak of haemolytic uraemic syndrome and bloody diarrhoea caused 
by a virulent Escherichia coli strain O104:H4 in Germany (with some cases elsewhere in Europe and 
North America), 810 cases of the syndrome and 39 deaths have occurred since the beginning of May, 
2011. We analysed virulence profiles and relevant phenotypes of outbreak isolates recovered in our 
laboratory. 
Methods: We analysed stool samples from 80 patients that had been submitted to the National 
Consulting Laboratory for Haemolytic Uraemic Syndrome in Münster, Germany, between May 23 and 
June 2, 2011. Isolates were screened with standard PCR for virulence genes of Shiga-toxin-producing 
E coli and a newly developed multiplex PCR for characteristic features of the outbreak strain (rfbO104, 
fliCH4, stx2, and terD). Virulence profiles of the isolates were determined with PCR targeting typical 
virulence genes of Shiga-toxin-producing E coli and of other intestinal pathogenic E coli. We 
sequenced stx with Sanger sequencing and measured Shiga-toxin production, adherence to epithelial 
cells, and determined phylogeny and antimicrobial susceptibility. 
Findings: All isolates were of the HUSEC041 clone (sequence type 678). All shared virulence profiles 
combining typical Shiga-toxin-producing E coli (stx2, iha, lpfO26, lpfO113) and enteroaggregative E coli 
(aggA, aggR, set1, pic, aap) loci and expressed phenotypes that define Shiga-toxin-producing E coli 
and enteroaggregative E coli, including production of Shiga toxing 2 and aggregative adherence to 
epithelial cells. Isolates additionally displayed an extended-spectrum β-lactamase phenotype absent in 
HUSEC041. 
 
Interpretation: Augmented adherence of the strain to intestinal epithelium might facilitate systemic 
absorption of Shiga toxin and could explain the high progression to haemolytic uraemic syndrome. 
This outbreak demonstrates that blended virulence profiles in enteric pathogens, introduced into 
susceptible populations, can have extreme consequences for infected people. 




Starting in early May, 2011, an outbreak of haemolytic uraemic syndrome and bloody diarrhoea 
caused by Escherichia coli O104:H4 has spread throughout Germany.
1
 As of June 20, 2011, 810 
cases of haemolytic uraemic syndrome, 2684 non-haemolytic uraemic syndrome cases, and 39 
deaths have been reported by the Robert Koch Institute and European Centre for Disease Prevention 
and Control. The particular features of this outbreak are the predominant involvement of adult women
1
 
and common severe neurological complications, such as encephalopathy and epileptic seizures. 
Almost 100 infections with 39 cases of haemolytic uraemic syndrome caused by the outbreak strain 
have been reported in other European states including Austria, the Czech Republic, Denmark, France, 
Greece, Luxemburg, the Netherlands, Norway, Poland, Spain, Sweden (including one death), and the 
UK and in Canada and the USA—most non-German patients seem to be travellers returning from 
Germany. In the past 15 years, only a single E coli O104:H4 has been isolated from a patient with 
haemolytic uraemic syndrome in Germany
2
 (HUSEC041, which is included in the collection of the 
National Consulting Laboratory for Haemolytic Uraemic Syndrome, University of Münster, Münster, 
Germany). A single additional case of the syndrome associated with E coli O104:H4 has also been 
reported from a woman in Korea.
3
 To gain insight into the apparently augmented virulence of the 
outbreak strain, we analysed virulence profiles and relevant phenotypes of outbreak isolates 




Stool samples and analysis 
The first stool sample from the suspected outbreak, originating from a patient with haemolytic uraemic 
syndrome, arrived at the National Consulting Laboratory for Haemolytic Uraemic Syndrome in 
Münster, Germany on May 23, 2011. By June 2, stools from 79 additional patients including 66 with 
haemolytic uraemic syndrome and 13 with bloody diarrhoea hospitalised in 22 hospitals in 17 different 
German cities distributed in nine of 16 federal states were received for microbiological analysis. The 
strains were isolated by use of stool enrichment in GN broth Hajna, plating the enriched cultures on 
extended-spectrum β-lactamase (ESBL) agar plates (chromID ESBL, bioMérieux, Nürtingen, 
Germany) and cefixime-tellurite sorbitol MacConkey agar (CT-SMAC, Oxoid, Wesel, Germany), and 
subsequent screening for stx, eae, and EHEC-hlyA with our standard PCR protocol.
4
 In addition, we 
developed and used multiplex PCR targeting typical molecular features of the outbreak strain (rfbO104, 
fliCH4, stx2, and terD; figure 1 and table 1). Multiplex PCR was done with the REDTaq ReadyMix PCR 
Reaction Mix (Sigma-Aldrich, Taufkirchen, Germany) in a total volume of 25 μL containing 2 μL of 
bacterial DNA. PCR conditions included initial denaturation at 94μC for 5 min, 30 cycles of 
denaturation (94°C, 30 s), annealing (55°C, 60 s), and extension (72°C, 60 s), and final extension at 
72°C for 5 min. fliC genes of the isolates encoding the H antigen were subtyped with fliC restriction 
fragment length polymorphism (RFLP).
7
 HUSEC041 (O104:H4) and HUSEC037 (O104:H21) strains 
were used for comparison with the outbreak isolates. 
 
Virulence analysis and antimicrobial susceptibility 
Virulence profiles of the outbreak isolates were compared with those of HUSEC041 by use of a set of 
PCR analyses targeting a broad range of virulence and fitness genes of Shiga-toxin producing E coli 
[5], [6], [7], [8], [9], [10], [11], [12] and [13]
 that typically cause haemolytic uraemic syndrome,
14
 such as those 
encoding toxins (stx1, stx2, EHEC-hlyA, cdt, subAB), serine proteases (espP), adhesins (eae, iha, 
lpfAO26, lpfAO113, lpfAO157-OI141, lpfAO157-OI154, saa, sfpA), iron acquisition system encoded on high 
pathogenicity island (marker genes irp2 and fyuA), and tellurite resistance (terD as a marker for the ter 
cluster). All isolates were PCR-tested for virulence loci typical for other intestinal pathogenic E coli 
including enteropathogenic (bfpA encoding structural subunit of bundle-forming pili), enterotoxigenic 
(elt and estI encoding heat-labile and heat-stable enterotoxin, respectively), enteroinvasive (ial, a 
marker for the virulence plasmid pInv), and enteroaggregative E coli (astA, sen, set1, and pic encoding 
toxins, aggA, aafA, agg3A, and agg4A encoding adhesins, aggR encoding transcription regulator, aap 
encoding dispersin, and aat as a marker for enteroaggregative E coli virulence plasmid). 




stx genes of four outbreak isolates from four different cities were amplified and Sanger sequenced; 
resulting sequences were analysed with the Ridom TraceEditPro Software (Ridom GmbH, Münster, 
Germany) and homologies were sought in GenBank. 
The isolates were confirmed as E coli (API 20 E, bioMérieux) and serotyped.
21
 β-D-glucuronidase 
activity was assessed by use of nutrient agar with 4-methylumbelliferyl-β-D-glucuronide (Becton 
Dickinson, Heidelberg, Germany). Production of enterohaemorrhagic E coli haemolysin was sought on 
enterohaemolysin agar (Sifin, Berlin, Germany), and production of α haemolysin on Columbia blood 
agar (Heipha, Heidelberg, Germany). Resistance to tellurite was determined by ability to grow on CT-
SMAC. Shiga-toxin production was identified with the Vero cell cytotoxicity assay.
4
 Adherence to 
human intestinal epithelial cells (HCT-8; ATCC CCL-244) was tested as described previously
22
 by use 
of semiconfluent monolayers incubated with the strains for 3 h in the presence of 0·5% D-mannose. 
Bacterial adherence patterns were examined with phase-contrast microscopy (AxioImagerA1; Zeiss, 
Jena, Germany) of washed, fixed, and Giemsa-stained cells. 
Antimicrobial susceptibility was determined by use of the Vitek 2 system version 05.02 (bioMérieux). 





Multilocus sequence typing (MLST) was done by sequencing internal fragments of seven 
housekeeping genes (adk, fumC, gyrB, icd, mdh, purA, and recA).
24
 The alleles and sequence type 
(ST) were assigned in accordance with the E coliMLST databases at the Environmental Research 
Institute, University College Cork, Ireland. In addition to MLST, all strains were subjected to partial gnd 
sequencing (627 bp internal gnd gene fragment, positions 397–1023 in strain W3110, GenBank 
accession number AP009048) in accordance to the protocol of Gilmour and colleagues
25
 Three 
reference E coli O104 strains including HUSEC041 (O104:H4), HUSEC037 (O104:H21), and 
enteroaggregative E coli strain 55989 (O104:H4; GenBank accession number NC_011748) were 
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Results 
The first outbreak strain (LB226692) was isolated in the German National Consulting Laboratory for 
Haemolytic Uraemic Syndrome in Münster on May 24, 2011. Molecular analysis of the isolate with 
PCR detected an stx2-positive, eae-negative Shiga-toxin-producing E coli, which was further 
characterised by sequence analysis of gnd, fliC RFLP, and MLST as gndO104, fliCH4, and ST678. 
Moreover, the strain grew on CT-SMAC and possessed ter cluster encoding tellurite resistance. These 
characteristics of the isolate enabled us to develop the multiplex PCR targeting the typical molecular 
features of the strain (rfbO104, fliCH4, stx2, and terD; figure 1), which we then used for identification of 
the subsequent outbreak isolates. We proved specificity of the multiplex PCR by showing that, among 
the 42 reference strains of the HUSEC collection and 100 additional Shiga-toxin-producing E coli of 
various serotypes as well as E coli from normal intestinal flora, only HUSEC041 gave amplicons for all 
the four loci targeted by the multiplex PCR. 
All 80 outbreak isolates possessed rfbO104 belonging to the O104 biosynthetic cluster and fliCH4 
belonging to the H4 antigen biosynthetic cluster, as determined by multiplex PCR (figure 1). gnd of all 
isolates was identical in the 627 bp sequenced fragment and it was identical to gnd of the two O104 
reference strains in the HUSEC collection (HUSEC037 and HUSEC041) and of strain 55989 
(GenBank accession number NC_011748), corroborating the O104 lipopolysaccharide phenotype. 
Presence of fliCH4 was verified using RFLP. All 80 isolates belonged to serotype O104:H4. All of them 
  
produced β-D-glucuronidase, fermented sorbitol and were tellurite resistant, and none produced 
enterohaemorrhagic E coli haemolysin or α haemolysin. All 80 isolates belonged to ST678, as does 
HUSEC041. This sequence type is unique to serotype O104:H4 among Shiga-toxin-producing E coli. 
On the basis of MLST, gnd sequence, and presence of fliCH4 we concluded that the isolates were a 
single clone. 
Each of the 80 outbreak isolates possessed virulence genes typical of Shiga-toxin-producing E coli, 
including stx2 encoding the toxin, iha, lpfO26, and lpfO113 encoding adhesins, and the high pathogenicity 
island originally identified in Yersiniae and encoding an iron uptake system;
13
eae encoding adhesin 
intimin
15
 was not present (table 2). The stx2 sequence was identical in four randomly chosen outbreak 
isolates and was 99% homologous to stx2 sequence of prototypic Shiga-toxin-producing E coli 
O157:H7 strain EDL933 (GenBank AE005174), with one synonymous nucleotide change in each 
subunit gene (stxA2 and stxB2). Moreover, all isolates possessed typical molecular characteristics of 
enteroaggregative E coli, 
[15], [16], [17], [18], [19] and [20]
 including the virulence plasmid (pAA), aggA encoding 
structural subunit of aggregative adherence fimbriae I (AAF/I), aggR encoding the enteroaggregative E 
coli global regulator AggR, aap encoding dispersin, set1 encoding Shigella enterotoxin 1, and pic 
encoding an autotransporter serine protease (protein involved in intestinal colonisation). None of the 
isolates contained astA encoding enteroaggregative E coli heat-stable enterotoxin 1 (table 2). The 
absence of astA and the presence of the genes encoding AAF/I fimbriae differentiate, among the 34 
alleles investigated, the outbreak isolates from HUSEC041, which contains astA as well as agg3A 
encoding the structural subunit of AAF/III fimbriae (table 2). These loci are also present in the 
reference enteroaggregative E coli strain 55989 (table 2). The results of the PCR analyses are 
concordant with the draft genome data of an outbreak isolate LB226692 (NCBI accession number 
AFPS01000000) after in-silico analysis of primer binding sites and the resulting fragment length 
determination. 
In addition to harbouring a mixture of virulence loci of two different intestinal E coli pathotypes, all 
O104:H4 outbreak isolates also express the phenotypes that define Shiga-toxin-producing E coli and 
enteroaggregative E coli, 
[15] and [16]
 specifically production of Shiga-toxin 2 (Vero cell cytotoxicity titres 
64–1024; median 256) and the aggregative (so-called stacked-brick) adherence pattern on intestinal 
epithelial cells (figure 2). The aggregative adherence phenotype (figure 2) combined with Shiga-toxin 2 
production (Vero cell titre 64) are also displayed by HUSEC041. Virulence loci typically found in other 
intestinal pathogenic E coli including enteropathogenic, enteroinvasive, and enterotoxigenic E coli are 
absent from the O104:H4 outbreak isolates and from HUSEC041 (table 2). 
All isolates have an ESBL phenotype—ie, they are resistant to all penicillins and cephalosporins and 
susceptible to carbapenems (ertapenem, imipenem, meropenem). This resistance pattern is typical for 
CTX-M-1 group β lactamases and corroborates the already reported findings of the CTX-M-15 
genotype.
26
 Furthermore, all strains are resistant to co-trimoxazole (trimethoprim–sulfamethoxazole) 
and susceptible to fluoroquinolones (ciprofloxacin) and aminoglycosides (gentamicin, tobramycin). 
HUSEC041 did not have the ESBL phenotype. 
 
Discussion 
The genotypes, phenotypes, and phylogeny of the 80 outbreak isolates demonstrate that the E coli 
O104:H4 outbreak strain is a clone that combines virulence potentials of two different pathogens: 
Shiga-toxin-producing E coli and enteroaggregative E coli (panel). HUSEC041, isolated in 2001 from a 





We searched the PubMed database for papers published in English between Jan 1, 1990, and June 
14, 2011, with the search terms “O104”, “O104:H4”, “HUS” (haemolytic uraemic syndrome), 
“enteroaggregative”, or “enterohaemorrhagic”. No articles provided a comprehensive characterisation 
of the enterohaemorrhagic Escherichia coli O104:H4 causing a large outbreak in Germany. 
 
Interpretation 
E coli O104:H4, which has characteristics and genetic loci found in Shiga-toxin-producing E coli and 
enteroaggregative E coli, is unprecedented among enteric pathogens in its virulence. This isolate 
belongs to the rare sequence type 678 and produces Shiga toxin 2 and aggregative adherence to 
intestinal epithelial cells. This pathogen, and this outbreak, will have profound implications for disease 
detection, reporting, food safety, and our understanding of microbial pathogenesis. 
Isolation of this rare E coli O104:H4 serotype in many samples and in a short time confirms that this is 
the outbreak strain; however, we do not have access to the entire strain collection from this outbreak 
because no single laboratory has statutory authority for the analysis or possession of these isolates. 
Because of the rapidly increasing number of infected people and the severity of the disease, 
identification and profiling of the outbreak strain as expeditiously as possible was essential. In this race 
against time, sequence analysis of gnd, identification of ST678 (which is unique to serotype O104:H4 
among Shiga-toxin-producing E coli, until now reported only in the HUSEC041 reference strain from 
2001), and identification of fliCH4 together with the presence of stx2 were the crucial points in 
determining the novelty of the strain just 2 days after the first stool arrived. This is of particular 
importance because in addition to E coli O104:H4, there are also other Shiga-toxin-producing E coli of 
serogroup O104, but these possess different H antigen.
27
 The most common is Shiga-toxin-producing 
E coli O104:H21 represented in our HUSEC collection by HUSEC037. An O104:H21 strain, which is 
similar to the E coli O104:H4 outbreak strain, also eae-negative, caused an outbreak of bloody 
diarrhoea associated with consumption of raw milk in Montana, USA, in 1994.
28
 
Taken together, the availability of the HUSEC collection including representative, well-characterised 
(genotypically and phenotypically) Shiga-toxin-producing E coli strains of all serotypes associated with 
haemolytic uraemic syndrome in Germany during the past 15 years and of gnd sequencing, fliC-RFLP 
and MLST enabled us in a very short time to identify the outbreak isolates as E coli O104:H4. These 
data and the rapidity with which the outbreak strain has been characterised show the value of standing 
collections of well characterised pathogens with known provenance, which was the purpose of the 
HUSEC collection. Moreover, implementation of well established, reproducible, and independent 
techniques, such as PCR and phenotypic tests available in our laboratory 
[4], [5], [6], [8], [12] and [22]
 enabled 
  
further rapid characterisation of the outbreak strain. The outbreak strain, which is a sorbitol fermenter, 
would have been missed by standard diagnostic procedures focused on the O157:H7 strain and using 
SMAC to identify this organism on the basis of its lack of sorbitol fermentation. However, the ESBL 
resistance of the outbreak strain aided its recovery from patients' stool samples by use of culture on 
ESBL agar. This feature might be used to seek reservoirs of this strain and to recover the organism 
from suspected vehicles of transmission. 
The reason for the apparently augmented virulence potential of the outbreak O104:H4 strain, as 
indicated by the high amount of haemolytic uraemic syndrome cases and 39 deaths, is unknown, but 
our data suggest some possibilities. The enhanced adherence of this strain to intestinal epithelial cells 
(figure 2) might facilitate systemic absorption of Shiga toxin and could explain the high frequency of 
progression to haemolytic uraemic syndrome. Antibiotic resistance might also play a part if β-lactam 
drugs used to treat the infection suppressed competing microbiota. When the outbreak strain acquired 
a plasmid encoding CTX-M-15, which is absent in the original HUSECO41 isolate from 2001, is 
unknown. This plasmid has been identified in several different genera in the Enterobacteriaceae.
29
 Our 
data do not permit us to state if the Shiga-toxin-producing and enteroaggregative traits in E coli 
O104:H4 combined recently, or if this pathogen is coming to light now because of conditions suitable 
for its spread. An E coli O111 strain that expressed Shiga toxin and displayed an aggregative 
adherence on epithelial cells
30
 caused an outbreak of haemolytic uraemic syndrome in France 15 
years ago,
31
 but the number of cases (ten) was lower than in the ongoing German outbreak (810 as of 
June 20). Differences in virulence potentials of the O111 and O104 outbreak strains, modes of 
transmission, the infectious dose present in the vehicle of infection (recently, sprouts have been 
identified as a source of the German outbreak),
32
 and general susceptibilities of the human hosts to 
these two strains might play a part. Although we lack an explanation for increased virulence, this 
outbreak tragically shows that blended virulence profiles in enteric pathogens introduced into 
susceptible populations can have serious consequences for infected people. 
 
Contributors 
MB and HK designed the study, analysed the data and wrote the paper. AM and RK isolated and AF 
serotyped the strains. AM, RK, and GP did the antimicrobial sensitivity tests. WZ developed and did 
the multiplex PCR for identification of E coli O104:H4. MB and WZ did the genomic analyses, and AB 
and MB the phenotypic studies. AB prepared the figures. HK and AM raised the funding. HK and GP 
supervised the study. 
 
Conflicts of interest 






We thank Phillip I Tarr (Washington University School of Medicine, St Louis, MO, USA) for extensive 
discussions of the Article. We also thank Nadine Brandt, Margret Junge, Ralph Fischer, and Andrea 
Lagemann for technical assistance. This study was supported by grants from the Federal Ministry of 
Education and Research Network Zoonoses (no 01KI07124 and 01KI07127, and PBA-Zoo project 





1. Frank C, Faber MS, Askar M, et al. Large and ongoing outbreak of haemolytic uraemic syndrome, 
Germany, May 2011. Euro Surveill 2011; 16: pii=19878. Published online May 26, 2011 http://www. 
eurosurveillance.org/ViewArticle.aspx?ArticleId=19878 (accessed June 1, 2011). 
2. Mellmann A, Bielaszewska M, Kock R, et al. Analysis of collection of hemolytic uremic syndrome-
associated enterohemorrhagic Escherichia coli. Emerg Infect Dis 2008; 14: 1287–90. 
3. Bae WK, Lee YK, Cho MS, et al. A case of hemolytic uremic syndrome caused by Escherichia coli 
104:H4. Yonsei Med J 2006; 47: 437–39. 
4. Bielaszewska M, Friedrich AW, Aldick T, Schurk-Bulgrin R, Karch H. Shiga toxin activatable by 
intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.  
Clin Infect Dis 2006; 43: 1160–67. 
5. Bielaszewska M, Zhang W, Tarr PI, Sonntag AK, Karch H. Molecular profi ling and phenotype 
analysis of Escherichia coli O26:H11 and O26:NM: secular and geographic consistency of 
enterohemorrhagic and enteropathogenic isolates. J Clin Microbiol 2005; 43: 4225–28. 
6. Bielaszewska M, Tarr PI, Karch H, Zhang W, Mathys W. Phenotypic and molecular analysis of 
tellurite resistance among enterohemorrhagic Escherichia coli O157:H7 and sorbitol-fermenting 
O157:NM clinical isolates. J Clin Microbiol 2005; 43: 452–54. 
7. Zhang W, Mellmann A, Sonntag AK, et al. Structural and functional differences between disease-
associated genes of enterohaemorrhagic Escherichia coli O111. Int J Med Microbiol 2007; 297: 17–
26. 
8. Bielaszewska M, Fell M, Greune L, et al. Characterization of cytolethal distending toxin genes and 
expression in Shiga toxin-producing Escherichia coli strains of non-O157 serogroups. 
Infect Immun 2004; 72: 1812–16. 
9. Paton AW, Paton JC. Direct detection and characterization of Shiga toxigenic Escherichia coli by 
multiplex PCR for stx1, stx2, eae, exhA, and saa. J Clin Microbiol 2002; 40: 271–74. 
10. Paton AW, Srimanote P, Talbot UM, Wang H, Paton JC. A new family of potent AB5 cytotoxins 
produced by Shiga toxigenic Escherichia coli. J Exp Med 2004; 200: 35–46. 
11. Toma C, Martinez Espinosa E, Song T, et al. Distribution of putative 
adhesins in diff erent seropathotypes of Shiga toxin-producing Escherichia coli. J Clin Microbiol 2004; 
42: 4937–46. 
12. Friedrich AW, Nierhoff KV, Bielaszewska M, Mellmann A, Karch H. Phylogeny, clinical 
associations, and diagnostic utility of the pilin subunit gene (sfpA) of sorbitol-fermenting, 
enterohemorrhagic Escherichia coli O157:H-. J Clin Microbiol 2004; 42: 4697–01. 
13. Karch H, Schubert S, Zhang D, et al. A genomic island, termed high pathogenicity island, is 
present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages. Infect Immun 
1999; 67: 5994–01. 
14. Karch H, Tarr PI, Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int J 
Med Microbiol 2005; 295: 405–18.  
15. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998; 11: 142–201. 
16. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol 2004; 2: 123–40. 
17. Okeke IN, Nataro JP. Enteroaggregative Escherichia coli. 
Lancet Infect Dis 2001; 1: 304–13. 
18. Vila J, Vargas M, Henderson IR, Gascon J, Nataro JP. Enteroaggregative Escherichia coli 
virulence factors in traveler‘s diarrhea strains. J Infect Dis 2000; 182: 1780–83. 
19. Muller D, Greune L, Heusipp G, et al. Identifi cation of unconventional intestinal pathogenic 
Escherichia coli isolates expressing intermediate virulence factor profi les by using a novel single-step 
multiplex PCR. Appl Environ Microbiol 2007; 73: 3380–90. 
20. Boisen N, Struve C, Scheutz F, Krogfelt KA, Nataro JP. New adhesin of enteroaggregative 
Escherichia coli related to the Afa/Dr/AAF family. Infect Immun 2008; 76: 3281–92. 
21. Prager R, Strutz U, Fruth A, Tschape H. Subtyping of pathogenic Escherichia coli strains using fl 
agellar (H)-antigens: serotyping versus fl iC polymorphisms. Int J Med Microbiol 2003; 292: 477–86. 
22. Aldick T, Bielaszewska M, Zhang W, et al. Hemolysin from Shiga toxin-negative Escherichia coli 
O26 strains injures microvascular endothelium. Microbes Infect 2007; 9: 282–90. 
23. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of 
MICs and zone diameters. http://www.eucast.org/fi leadmin/src/media/PDFs/EUCAST_fi les/ 
Disk_test_documents/EUCAST_breakpoints_v1.3_pdf (accessed June 20, 2011). 
24. Wirth T, Falush D, Ruiting L, et al. Sex and virulence in Escherichia coli: an evolutionary 
perspective. Mol Microbiol 2006; 60: 1136–51. 
25. Gilmour MW, Olson AB, Andrysiak AK, Ng L, Chui L. Sequencebased typing of genetic targets 
encoded outside of the O-antigen gene cluster is indicative of Shiga toxin-producing Escherichia coli 
  
serogroup lineages. J Med Microbiol 2007; 56: 620–28. 
26. Robert Koch Institute. Aktualisierte Hinweise und Hilfestellungen des RKI zur Diagnostik des 
gegenwartig zirkulierenden Ausbruchstammes. http://www.rki.de/cln_144/nn_467482/DE/ 
Content/InfAZ/E/EHEC/EHEC__Diagnostik,templateId=raw,property=publicationFile.pdf/EHEC_Diagn
ostik.pdf (accessed June 20, 2011). 
27. European Centre for Disease Prevention and Control and European Food Safety Authority. Shiga 
toxin/verotoxin-producing Escherichia coli in humans, food and animals in the EU/EEA, with special 
reference to the German outbreak strain STEC O104. Stockholm: ECDC; 2011. 
28. Centers for Disease Control and Prevention. Outbreak of acute gastroenteritis attributable to 
Escherichia coli serotype O104:H21–Helena, Montana, 1994. MMWR Morb Mortal Wkly Rep 
1995; 44: 501–03.  
29. Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob 
Agents Chemother 2004; 48: 1–14. 
30. Morabito S, Karch H, Mariani-Kurkdjian P, et al. Enteroaggregative, Shiga toxin-producing 
Escherichia coli O111:H2 associated with an outbreak of hemolytic-uremic syndrome. J Clin Microbiol 
1998; 36: 840–42. 
31. Boudaillez B, Berquin P, Mariani-Kurkdjian P, et al. Possible person-to-person transmission of 
Escherichia coli O111-associated hemolytic uremic syndrome. Pediatr Nephrol 1996; 11: 36–39. 
32. Bundesinstitut fur Risikobewertung. EHEC outbreak: BfR confi rms contamination of sprouts with 
O104:H4. Federal Institute for Risk Assessment (BfR) Germany, 2011. Published online June 11, 
2011 
http://www.bfr.bund.de/de/presseinformation/2011/17/ehec_ausbruch__bfr_bestaetigt_kontamination_
von_sprossen_mit_0104_h4-70934.html (accessed June 11, 2011).
  
Tables and Figures 
 
 






Table 2. Virulence loci of 80 Escherichia coli O104:H4 outbreak isolates by pathogroup, compared 
with HUSEC041 and enteroaggregative E coli strain 55989 
 
  
Figure 1. Detection of Escherichia coli O104:H4 outbreak strainThe amplicons are stx2 (584 bp), terD 
(434 bp), rfbO104 (351 bp), fliCH4 (201 bp). Lane 1: HUSEC037 (O104:H21; stx2-positive, terD-negative, 
rfbO104 -positive, fliCH4-negative). Lanes 2 and 3: E coli O104:H4 outbreak isolates LB226692 and 
LB226541, respectively. Lane 4: E coli K12 negative control. Lane 5: reagent control. M: 100 kb 















Figure 2. Aggregative, so called, stacked-brick adherence to cultured intestinal epithelial 
cellsOutbreak Escherichia coli O104:H4 isolate LB226692 (A). An enteroaggregative E coli strain 
(positive control; B). HUSEC041 (C). HUSEC037 (negative control; D). 
 
 
 
 
 
 
 
 
 
 
